Life after hepatitis C cure in HIV-infected people who inject drugs and men who have sex with men treated with direct-acting antivirals in France: Health perceptions and experiences from qualitative and quantitative findings (ANRS CO13 HEPAVIH)
- PMID: 32810905
- PMCID: PMC7935320
- DOI: 10.1111/jvh.13378
Life after hepatitis C cure in HIV-infected people who inject drugs and men who have sex with men treated with direct-acting antivirals in France: Health perceptions and experiences from qualitative and quantitative findings (ANRS CO13 HEPAVIH)
Abstract
There remains a substantial gap in our understandings of the life experiences of patients following HCV cure among HIV-HCV-co-infected people who inject drugs (PWID) and men who have sex with men (MSM), two key populations targeted for HCV elimination. We described the experiences and perspectives of HIV-positive PWID and MSM, HCV-cured following treatment with direct-acting antivirals (DAA). We used an exploratory sequential mixed approach using both qualitative data (semi-structured interviews with 27 PWID and 20 MSM) and quantitative data (self-administered questionnaires with 89 PWID) via the prospective ANRS CO13 HEPAVIH cohort. PWID reported improvements in physical health-related quality of life (HRQL) and self-reported symptoms following treatment, but no significant change in mental HRQL. During interviews, several MSM, more recently diagnosed with HCV, expressed less concern regarding HCV than HIV infection and interpreted improvements in their overall well-being after HCV cure to be more related to a closer connection with healthcare providers than with viral elimination. By contrast, PWID, particularly those previously exposed to interferon-based treatments, described major improvements in their physical HRQL. Both MSM and PWID reported improvements in cognitive or psychological wellbeing, and a majority of them reported some degree of concern over potential HCV reinfection. To conclude, though health benefits of HCV cure concern both groups, HIV-infected PWID and MSM may have different representations and experiences following DAA treatment, related to their history with HCV. They are thus likely to benefit from holistic, post-treatment follow-up care that is responsive to their evolving health and social contexts.
Keywords: HIV-HCV co-infection; direct-acting antivirals; men who have sex with men; mixed methods; people who inject drugs.
© 2020 John Wiley & Sons Ltd.
Conflict of interest statement
CONFLICT OF INTEREST
All authors have no conflicts to declare.
Similar articles
-
"Stigma is where the harm comes from": Exploring expectations and lived experiences of hepatitis C virus post-treatment trajectories among people who inject drugs.Int J Drug Policy. 2021 Oct;96:103238. doi: 10.1016/j.drugpo.2021.103238. Epub 2021 Apr 23. Int J Drug Policy. 2021. PMID: 33902968 Free PMC article.
-
All-cause mortality before and after DAA availability among people living with HIV and HCV: An international comparison between 2010 and 2019.Int J Drug Policy. 2024 Feb;124:104311. doi: 10.1016/j.drugpo.2023.104311. Epub 2024 Jan 6. Int J Drug Policy. 2024. PMID: 38184902
-
Reinfection With the Hepatitis C Virus in Men Who Have Sex With Men After Successful Treatment With Direct-acting Antivirals in Germany: Current Incidence Rates, Compared With Rates During the Interferon Era.Clin Infect Dis. 2020 Aug 22;71(5):1248-1254. doi: 10.1093/cid/ciz949. Clin Infect Dis. 2020. PMID: 31562816
-
Is hepatitis C virus elimination possible among people living with HIV and what will it take to achieve it?J Int AIDS Soc. 2018 Apr;21 Suppl 2(Suppl Suppl 2):e25062. doi: 10.1002/jia2.25062. J Int AIDS Soc. 2018. PMID: 29633560 Free PMC article. Review.
-
HCV Cure and Reinfection Among People With HIV/HCV Coinfection and People Who Inject Drugs.Curr HIV/AIDS Rep. 2017 Jun;14(3):110-121. doi: 10.1007/s11904-017-0358-8. Curr HIV/AIDS Rep. 2017. PMID: 28432579 Review.
Cited by
-
"Like a pickle that's been unpickled": Emotional, identity and behavioural transformations throughout hepatitis C treatment.PLoS One. 2022 Dec 12;17(12):e0272401. doi: 10.1371/journal.pone.0272401. eCollection 2022. PLoS One. 2022. PMID: 36508406 Free PMC article.
-
Reaching the Unreachable: Strategies for HCV Eradication in Patients With Refractory Opioid Addiction-A Real-world Experience.Open Forum Infect Dis. 2021 Jun 17;8(8):ofab325. doi: 10.1093/ofid/ofab325. eCollection 2021 Aug. Open Forum Infect Dis. 2021. PMID: 34377724 Free PMC article.
-
Hepatitis C cure as a 'gathering': Attending to the social and material relations of hepatitis C treatment.Sociol Health Illn. 2022 Apr;44(4-5):830-847. doi: 10.1111/1467-9566.13467. Epub 2022 Apr 1. Sociol Health Illn. 2022. PMID: 35365924 Free PMC article.
-
"Stigma is where the harm comes from": Exploring expectations and lived experiences of hepatitis C virus post-treatment trajectories among people who inject drugs.Int J Drug Policy. 2021 Oct;96:103238. doi: 10.1016/j.drugpo.2021.103238. Epub 2021 Apr 23. Int J Drug Policy. 2021. PMID: 33902968 Free PMC article.
References
-
- Cacoub P, Dabis F, Costagliola D, et al. Burden of HIV and hepatitis C co-infection: the changing epidemiology of hepatitis C in HIV-infected patients in France. Liver Int Off J Int Assoc Study Liver. 2015;35(1):65–70. - PubMed
-
- Graham CS, Baden LR, Yu E, et al. Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis. Clin Infect Dis Off Publ Infect Dis Soc Am. 2001;33(4):562–569. - PubMed
-
- Thein H-H, Yi Q, Dore GJ, Krahn MD. Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis. AIDS Lond Engl. 2008;22(15):1979–1991. - PubMed
-
- Alter MJ, Margolis HS, Krawczynski K, et al. The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. N Engl J Med. 1992;327(27):1899–1905. - PubMed
-
- Thomas DL, Astemborski J, Rai RM, et al. The natural history of hepatitis C virus infection: host, viral, and environmental factors. JAMA. 2000;284(4):450–456. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous